Social Capital Suvretta Holdings Corp. III (DNAC) News Today → At first glance, this chart looks like nonsense… (From The TradingPub) (Ad) Free DNAC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBooz Allen Hamilton Holding Corporation (BAH)finance.yahoo.com - February 10 at 10:14 PMCGrowth Capital Inc. Bolsters Mining Division with Team Expansion and Expert Appointmentsmarkets.businessinsider.com - December 12 at 6:42 PMCGrowth Capital Secures $1 Million in Non-Debt Financingmarkets.businessinsider.com - November 16 at 5:01 PMOji Holdings Corp. (3861)investing.com - November 1 at 3:44 PMKuriyama Holdings Corp (3355)investing.com - October 24 at 8:04 PMLeader Capital Holdings Corp.wsj.com - July 22 at 5:23 PMSocial Capital Suvretta Holdings Corp II Class Amorningstar.com - April 5 at 9:34 PMBREZ Breeze Holdings Acquisition Corp.seekingalpha.com - January 24 at 10:20 AMSocial Capital Suvretta Holdings Corp II Class A DNAB Stock Quotemorningstar.com - December 23 at 12:00 AMCredit Suisse Raises $4.3 Billion Capital for Restructuringbloomberg.com - December 8 at 8:25 PMFerrotec Holdings Corpreuters.com - November 28 at 10:56 PMWinston-Salem regenerative medicine company ProKidney goes public through $600M merger with 'SPAC King'finance.yahoo.com - July 15 at 4:12 PMWinston-Salem regenerative medicine company ProKindey goes public through $600M merger with 'SPAC King'bizjournals.com - July 13 at 4:03 PMProKidney goes public through merger with SPAC Social Capital Suvretta, stock slides 7%seekingalpha.com - July 12 at 4:02 PMRevolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. IIIfinance.yahoo.com - July 12 at 10:09 AMSocial Capital Suvretta Holdings Corp. III Announces Reconvened Extraordinary General Meeting of Shareholdersfinance.yahoo.com - July 8 at 8:45 PMSPAC Social Capital Suvretta III delays shareholder vote on ProKidney mergerseekingalpha.com - July 7 at 5:52 PMProKidney Corroborates the Mechanism of Action of REACT™ with Cell Marker Analysis in Patients with Diabetic Chronic Kidney Diseasefinance.yahoo.com - June 23 at 9:26 AMProKidney Announces Manufacturing Efficiency Initiatives and Supply Chain Streamlining Expected to Reduce REACT™ Manufacturing Costsfinance.yahoo.com - June 15 at 10:07 AMObserved Safety Profile Supports Bilateral Dosing of ProKidney's REACT™ - 007 Updatetmcnet.com - June 7 at 11:28 AMObserved Safety Profile Supports Bilateral Dosing of ProKidney’s REACT™ – 007 Updatefinance.yahoo.com - June 7 at 11:28 AMProKidney to present at upcoming investor conferencesfinance.yahoo.com - May 20 at 9:21 AMProKidney highlights key registrational program elements supporting advancement of REACT®benzinga.com - May 3 at 9:58 AMProKidney highlights key registrational program elements supporting advancement of REACT®finance.yahoo.com - May 3 at 9:58 AMProKidney Appoints Libbie Parker McKenzie, MD, FASN as Chief Medical Officertmcnet.com - April 28 at 8:35 AMProKidney and Social Capital Suvretta Holdings Corp. III (“SCS”) to Host Analyst and Investor Day on April 28, 2022finance.yahoo.com - April 18 at 9:42 AMProKidney confirms Phase 3 program for autologous kidney cell therapy REACT®finance.yahoo.com - April 12 at 12:26 PMProKidney Appoints Todd C. Girolamo as General Counselapnews.com - March 28 at 11:21 PMProKidney Announces Online Publication of Trial Design for Phase II Multicenter Clinical Trial of REACT® Autologous Cell Therapy for Treatment of Chronic Kidney Diseasefinance.yahoo.com - January 27 at 9:12 AMDNAC Stock Alert: Chamath Palihapitiya’s SPAC Preps for ProKidney Mergerfinance.yahoo.com - January 26 at 3:10 AMPalihapitiya’s SPAC to Merge With ProKidney in $2.6 Billion Dealfinance.yahoo.com - January 18 at 8:20 AMRevolutionary Chronic Kidney Disease Therapeutics Company ProKidney to Become Publicly Traded via Business Combination with Social Capital Suvretta Holdings Corp. IIIfinance.yahoo.com - January 18 at 8:20 AMProKidney set to go public after SPAC merger that values combined company at $2.6 billionfinance.yahoo.com - January 18 at 8:20 AMmarketbeat.com - January 18 at 6:56 AMSocial Capital Suvretta Holdings Corp. III Announces Pricing of Upsized $220,000,000 Initial Public Offeringfinance.yahoo.com - August 2 at 8:16 AM Get Social Capital Suvretta Holdings Corp. III News Delivered to You Automatically Sign up to receive the latest news and ratings for DNAC and its competitors with MarketBeat's FREE daily newsletter. Email Address At first glance, this chart looks like nonsense… (Ad)We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates” But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… DNAC Media Mentions By Week DNAC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DNAC News Sentiment▼0.000.44▲Average Medical News Sentiment DNAC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DNAC Articles This Week▼00▲DNAC Articles Average Week Get Social Capital Suvretta Holdings Corp. III News Delivered to You Automatically Sign up to receive the latest news and ratings for DNAC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: KOD News ELEV News CRDF News XFOR News ABOS News CHRS News CMPX News IPSC News OPT News SCLX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DNAC) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceNew Trump BombshellThe Freeport SocietyGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Social Capital Suvretta Holdings Corp. III Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
